EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (MITOS: EROS+CP US Study)

CompletedOBSERVATIONAL

Enrollment

13,000

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

BGF

BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL

Trial Locations (1)

AstraZeneca, Wilmington